Unlike PCA, which is usually adenocarcinoma, NEPC tumors lose their dependence on AR signaling, and the regulation of many metabolic processes by AR is correspondingly reduced, the activation of related signaling pathways and chromatin modifications lead to metabolic reprogramming [98]. This evidence concerns the gene AR and adenocarcinoma.